Hip resurfacing arthroplasty and total hip arthroplasty in the same patient: which do they prefer?


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 17 10 2019
medline: 13 5 2021
entrez: 17 10 2019
Statut: ppublish

Résumé

Hip resurfacing arthroplasty (HRA) is an alternative to conventional total hip arthroplasty (THA) with potential advantages of preserving femoral bone stock and the ability to participate in higher impact activities. This study compares outcomes, satisfaction and preference in patients who underwent HRA in 1 hip and THA on the contralateral side. 62 Patients with an HRA in 1 hip and a contralateral THA were retrospectively identified at 3 centres, consisting of 38 males and 24 females with 53 patients (85.5%) undergoing HRA first. A survey regarding satisfaction and preference for each procedure and outcome scores were obtained. Patients were younger (51.5 vs. 56.6 years, Although HRA is associated with risks related to metal-on-metal bearings, it showed greater increase in patient-reported outcomes and a small subjective preference amongst patients who have undergone both conventional and resurfacing arthroplasty.

Identifiants

pubmed: 31615288
doi: 10.1177/1120700019882922
doi:

Substances chimiques

Metals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-334

Auteurs

Tyler E Calkins (TE)

Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennesse - Campbell Clinic Orthopaedics, Memphis, TN, USA.

Linda I Suleiman (LI)

Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Chris Culvern (C)

Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.

Sulaiman Alazzawi (S)

Department of Orthopaedic Surgery, University College London Hospitals, London, UK.

Gregory S Kazarian (GS)

Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO, USA.

Robert L Barrack (RL)

Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO, USA.

Fares S Haddad (FS)

Department of Orthopaedic Surgery, University College London Hospitals, London, UK.

Craig J Della Valle (CJ)

Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH